CUBELLIS, MARIA VITTORIA
 Distribuzione geografica
Continente #
AS - Asia 4.113
NA - Nord America 3.511
EU - Europa 2.414
SA - Sud America 453
AF - Africa 107
OC - Oceania 6
Continente sconosciuto - Info sul continente non disponibili 5
Totale 10.609
Nazione #
US - Stati Uniti d'America 3.378
SG - Singapore 1.975
RU - Federazione Russa 1.232
VN - Vietnam 766
CN - Cina 680
BR - Brasile 350
HK - Hong Kong 334
IT - Italia 277
FR - Francia 155
DE - Germania 149
FI - Finlandia 116
UA - Ucraina 97
SE - Svezia 80
GB - Regno Unito 77
IE - Irlanda 77
CA - Canada 71
JP - Giappone 60
IN - India 56
NL - Olanda 49
AR - Argentina 46
CI - Costa d'Avorio 37
MX - Messico 37
BD - Bangladesh 32
KR - Corea 32
PL - Polonia 29
IQ - Iraq 27
ZA - Sudafrica 23
AT - Austria 22
PH - Filippine 22
TH - Thailandia 22
ID - Indonesia 17
TR - Turchia 16
ES - Italia 15
PK - Pakistan 15
CO - Colombia 13
PY - Paraguay 13
EC - Ecuador 11
KE - Kenya 9
VE - Venezuela 9
UZ - Uzbekistan 8
CL - Cile 7
LT - Lituania 7
MA - Marocco 7
DZ - Algeria 6
EG - Egitto 6
TW - Taiwan 6
AU - Australia 5
IL - Israele 5
GT - Guatemala 4
PS - Palestinian Territory 4
TT - Trinidad e Tobago 4
AE - Emirati Arabi Uniti 3
BE - Belgio 3
CH - Svizzera 3
DK - Danimarca 3
HU - Ungheria 3
JM - Giamaica 3
JO - Giordania 3
KZ - Kazakistan 3
LB - Libano 3
LU - Lussemburgo 3
NP - Nepal 3
OM - Oman 3
PA - Panama 3
RO - Romania 3
SA - Arabia Saudita 3
XK - ???statistics.table.value.countryCode.XK??? 3
AZ - Azerbaigian 2
BN - Brunei Darussalam 2
CG - Congo 2
DO - Repubblica Dominicana 2
ET - Etiopia 2
MN - Mongolia 2
MY - Malesia 2
PE - Perù 2
PR - Porto Rico 2
SC - Seychelles 2
SK - Slovacchia (Repubblica Slovacca) 2
TN - Tunisia 2
AL - Albania 1
AM - Armenia 1
BA - Bosnia-Erzegovina 1
BB - Barbados 1
BF - Burkina Faso 1
BH - Bahrain 1
BO - Bolivia 1
BY - Bielorussia 1
BZ - Belize 1
CR - Costa Rica 1
CW - ???statistics.table.value.countryCode.CW??? 1
CY - Cipro 1
CZ - Repubblica Ceca 1
DM - Dominica 1
EE - Estonia 1
EU - Europa 1
GA - Gabon 1
GD - Grenada 1
GY - Guiana 1
HN - Honduras 1
HR - Croazia 1
Totale 10.588
Città #
Singapore 976
San Jose 507
Hong Kong 322
Chandler 317
Moscow 310
Santa Clara 289
Ashburn 214
Ho Chi Minh City 194
Beijing 182
Hanoi 163
Lauterbourg 101
The Dalles 97
Hefei 96
Los Angeles 93
Jacksonville 92
Millbury 84
Princeton 83
Boston 78
New York 68
Nanjing 63
Naples 50
Tokyo 50
Munich 45
Napoli 44
Redondo Beach 44
Da Nang 43
Buffalo 39
Wilmington 35
Des Moines 34
Ottawa 34
Amsterdam 32
Haiphong 31
Orem 31
Dallas 27
São Paulo 26
Warsaw 25
Chicago 23
Mexico City 22
Nanchang 22
Frankfurt am Main 20
Nuremberg 20
Denver 19
Brooklyn 18
Council Bluffs 18
Lawrence 18
Seoul 18
Hebei 17
Lappeenranta 17
Seattle 17
Chennai 16
Stockholm 16
Woodbridge 15
Ann Arbor 14
Atlanta 14
Biên Hòa 14
Poplar 14
Shenyang 14
St Petersburg 14
Baghdad 13
Falls Church 13
London 13
Montreal 13
Norwalk 13
Dong Ket 12
Hải Dương 12
Jiaxing 12
San Francisco 12
Helsinki 11
Manchester 11
Milan 11
Rome 11
Vienna 11
Belo Horizonte 10
Boardman 10
Johannesburg 10
Kronberg 10
Paris 10
Phoenix 10
Bangkok 9
Bình Phước 9
Falkenstein 9
Nha Trang 9
Ninh Bình 9
Toronto 9
Dublin 8
Guangzhou 8
Houston 8
Mumbai 8
New Delhi 8
Tashkent 8
Tianjin 8
Ankara 7
Berlin 7
Brasília 7
Casavatore 7
Changsha 7
Fairfield 7
Điện Bàn 7
Asunción 6
Bắc Giang 6
Totale 5.698
Nome #
PHYSICO-CHEMICAL CHARACTERZATION OF GEODIN: A NEW B, G- CRYSTALLINE- TYPE PROTEIN SPONGE 171
Ribonucleases and angiogenins from fish. 162
A mutant of phosphomannomutase1 retains full enzymatic activity, but is not activated by IMP: Possible implications for the disease PMM2-CDG 149
Pharmacological chaperones: A therapeutic approach for diseases caused by destabilizing missense mutations 147
The Analysis of Variants in the General Population Reveals That PMM2 Is Extremely Tolerant to Missense Mutations and That Diagnosis of PMM2-CDG Can Benefit from the Identification of Modifiers 142
Why does SARS-CoV-2 hit in different ways? Host genetic factors can influence the acquisition or the course of COVID-19 137
Protective role of a tmprss2 variant on severe covid-19 outcome in young males and elderly women 136
Drug Repositioning for Fabry Disease: Acetylsalicylic Acid Potentiates the Stabilization of Lysosomal Alpha-Galactosidase by Pharmacological Chaperones 134
Heterodimerization of Two Pathological Mutants Enhances the Activity of Human Phosphomannomutase2 133
The polymorphism L412F in TLR3 inhibits autophagy and is a marker of severe COVID-19 in males 128
D2A-Ala peptide derived from the urokinase receptor exerts anti-tumoural effects in vitro and in vivo 127
Bioinformatics tools for marine biotechnology: A practical tutorial with a metagenomic approach 127
β-Glucose-1,6-Bisphosphate Stabilizes Pathological Phophomannomutase2 Mutants In Vitro and Represents a Lead Compound to Develop Pharmacological Chaperones for the Most Common Disorder of Glycosylation, PMM2-CDG 120
Relaxation of Insulin-like growth factor-2 imprinting and discordant methylation at KvDMR1 in two first-cousins affected by Beckwith-Wiedemann and Klippel-Trenaunay-Weber syndromes 119
In vitro enzyme measurement to test pharmacological chaperone responsiveness in fabry and pompe disease 117
Indole-3-glycerol-phosphate Synthase From Sulfolobus-solfataricus As A Model For Studying Thermostable Tim-barrel Enzymes 116
Novel genetic variants of KHDC3L and other members of the subcortical maternal complex associated with Beckwith–Wiedemann syndrome or Pseudohypoparathyroidism 1B and multi-locus imprinting disturbances 116
Inherited and Sporadic Epimutations at the IGF2-H19 locus in Beckwith-Wiedemann syndrome and Wilms' tumor. 115
The Functioning of Sulfolobus-solfataricus Aspartate-aminotransferase 115
Identification of an Allosteric Binding Site on Human Lysosomal Alpha-Galactosidase Opens the Way to New Pharmacological Chaperones for Fabry Disease 115
The Large Phenotypic Spectrum of Fabry Disease Requires Graduated Diagnosis and Personalized Therapy: A Meta-Analysis Can Help to Differentiate Missense Mutations 115
Stability of a thermophilic TIM-barrel enzyme: indolglycerol-phosphate synthase from the thermophilic archaeon Sulfolobus solfataricus. 114
Loss-of-function maternal-effect mutations of PADI6 are associated with familial and sporadic Beckwith-Wiedemann syndrome with multi-locus imprinting disturbance 114
Data on the inhibition of cell proliferation and invasion by the D2A-Ala peptide derived from the urokinase receptor 114
Curcumin Has Beneficial Effects on Lysosomal Alpha-Galactosidase: Potential Implications for the Cure of Fabry Disease 113
Expression of a hyperthermophilic aspartate aminotransferase in Escherichia coli 112
Challenging popular tools for the annotation of genetic variations with a real case, pathogenic mutations of lysosomal alpha-galactosidase 112
Proteostasis regulators modulate proteasomal activity and gene expression to attenuate multiple phenotypes in Fabry disease 112
Molecular characterization of G6PD deficiency in Southern Italy: heterogeneity, correlation genotype-phenotype and description of a new variant (G6PD Neapolis). 111
Looking for protein stabilizing drugs with thermal shift assay. 111
Stability of aspartate aminotransferase from Sulfolobus solfataricus. 110
Drug repositioning can accelerate discovery of pharmacological chaperones. 110
A maternal-effect Padi6 variant causes nuclear and cytoplasmic abnormalities in oocytes, as well as failure of epigenetic reprogramming and zygotic genome activation in embryos 109
IN SILICO DOCKING OF UROKINASE PLASMINOGEN ACTIVATOR AND INTEGRINS 109
Limited proteolysis as a probe of conformational changes in aspartate aminotransferase from Sulfolobus solfataricus 109
Aspartate-aminotransferase From Sulfolobus-solfataricus - A Hyperthermophilic Enzyme 109
An intron-less betagamma-crystallin-type gene from the sponge Geodia cydonium. 107
D2A sequence of the urokinase receptor induces cell growth through αvβ3 integrin and EGFR 105
Tryptophan Biosynthesis Genes TrpEGC In the Thermoacidophilic Archaebacterium Sulfolobus-solfataricus 104
PEGYLATION, THE ULTIMATE STRATEGY TO IMPROVE THE IN VIVO EFFICIENCY OF BIOACTIVE COMPOUNDS 104
Identification of trombospondin-1 as a novel amelogenin interactor by functional proteomics 103
A Key Molecule Dictating and Regulating Surface Plasmin Formation : The Receptor for Urokinase Plasminogen ActivatorSerine Proteases and Their Serpin Inhibitors in the Nervous System 102
Properties of polyproline II, a secondary structure element implicated in protein-protein interaction 101
An extremely thermostable aromatic aminotransferase from the hyperthermophilic archaeon Pyrococcus furiosus. 101
Biallelic variant in cyclin B3 is associated with failure of maternal meiosis II and recurrent digynic triploidy 101
Mechanistic Insight into the Mode of Action of Acid β-Glucosidase Enhancer Ambroxol 101
Drug Repurposing and Lysosomal Storage Disorders: A Trick to Treat 101
Inherited and Sporadic Epimutations at the IGF2-H19 Locus in Beckwith-Wiedemann Syndrome and Wilms’ Tumor. In: Endocrine Involvement in Developmental Syndromes. 99
ReBaTSA: A simplified CeTSA protocol for studying recombinant mutant proteins in bacterial extracts 98
Passenger mutations as a target for the personalized therapy of cancer 98
An EcoRI polymorphism for the PLAUR gene 96
Use of fast protein liquid chromatography (FPLC) for the purification of synthetic oligonucleotides 95
Stability of aspartate aminotransferase from Sulfolobus solfataricus 95
Assessment of gene variant amenability for pharmacological chaperone therapy with 1-deoxygalactonojirimycin in fabry disease 95
Environment specific substitution tables for thermophilic proteins 94
Comparative studies on thermophilicity and thermostability of aspartate aminotransferases. 93
Secondary structure assignment that more accurately reflects physical and evolutionary characteristics. 92
Different Mechanisms Cause Imprinting defects at the IGF2/H19 locus in Beckwith-Wiedemann Syndrome and Wilms’ Tumour. 92
The active site of Sulfolobus solfataricus aspartate aminotransferase 90
Exploring ligand interactions with human phosphomannomutases using recombinant bacterial thermal shift assay and biochemical validation 89
Enzymes from extreme thermophilic bacteria as special catalysts: studies on a beta -galactosidase from Sulfolobus solfataricus 87
An intron-less βγ-crystallin-type gene from the sponge Geodia cydonium 85
Conformational response to ligand binding in phosphomannomutase2: insights into inborn glycosylation disorder. 84
Identification of a novel mutation in the myosin VIIA motor domain in a family with autosomal dominant hearing loss (DFNA11). 83
Use of fast protein liquid chromatography for the purification of synthetic oligonucleotides 83
Autocrine saturation of pro-urokinase receptors on human A431 cells. 83
An open reading frame in intron seven of the sea urchin DNA-methyltransferase gene codes for a functional AP1 endonuclease. 82
Fabry_CEP: a tool to identify Fabry mutations responsive to pharmacological chaperones. 81
(Epi)genotype-phenotype correlations in Beckwith-Wiedemann syndrome. 81
The KCNQ1OT1 Imprinting Control Region and non-coding RNA: new properties derived from the study of Beckwith-Wiedemann syndrome and Silver-Russell syndrome cases. 80
Relaxation of Insulin-like Growth Factor 2 Imprinting and Discordant Methylation at KvDMR1 in Two First Cousins Affected by Beckwith-Wiedemann and Klippel-Trenaunay-Weber Syndromes 80
Frequent pathological human mutations: a survey. 80
Antitumor Action of Seminal Ribonuclease, Its Dimeric Structure, and Its Resistance to the Cytosolic Ribonuclease Inhibitor† 79
The pharmacological chaperone 1-deoxynojirimycin increases the activity and lysosomal trafficking of multiple mutant forms of acid alpha-glucosidase 78
Polyproline II in protein interactions 76
The receptor for urokinase-plasminogen activator 76
Biochemical phenotype of a common disease-causing mutation and a possible therapeutic approach for the phosphomannomutase 2-associated disorder of glycosylation 75
Gain of function in CDKN1C 74
Binding of single-chain prourokinase to the urokinase receptor of human U937 cells. 74
Cloning and expression of the receptor for human urokinase plasminogen activator, a central molecule in cell surface, plasmin dependent proteolysis. 74
An ORF in the intron seven of the sea urchin DNA-methyltransferase gene codes for a functional AP1 endonuclease 73
A thermodynamic assay to test pharmacological chaperones for Fabry disease. 71
The urokinase receptor and regulation of cell surface plasminogen activation 68
Accessibility of receptor-bound urokinase to type-1 plasminogen activator inhibitor. 67
Bioinformatics-Driven Multi-Factorial Insight into α-Galactosidase Mutations 66
Characterization of aromatic aminotransferases from the hyperthermophilic archaeon Thermococcus litoralis. 66
Use of Fast Protein Liquid-chromatography For the Purification of Synthetic Oligonucleotides 66
Cloning, Sequencing and Expression of A New Beta-galactosidase From the Extreme Thermophilic Sulfolobus-solfataricus 66
In Silico Analysis of Phosphomannomutase-2 Dimer Interface Stability and Heterodimerization with Phosphomannomutase-1 65
Fetal growth patterns in Beckwith-Wiedemann syndrome 65
Beneficial effects of Glc-1,6-P2 modulation on mutant phosphomannomutase-2 64
Identification of a novel mutation in the myosin VIIA motor domain in a family with autosomal dominant hearing loss (DFNA11). 64
Prediction of the responsiveness to pharmacological chaperones: lysosomal human alpha-galactosidase, a case of study 64
Silver-Russell syndrome- and Beckwith-Wiedemann syndrome- phenotypes associated with 11p duplication in a single family. 63
Isolation and sequencing of a new β-galactosidase-encoding archaebacterial gene 63
Preparation and characterization of geodin. A betagamma-crystallin-type protein from a sponge. 62
Hypomethylation at multiple maternally methylated imprinted regions including PLAGL1 and GNAS loci in Beckwith-Wiedemann syndrome. 62
Nucleotide sequence of a cDNA coding for bovine mitochondrial aspartate aminotransferase. 62
Cloning and sequencing of the gene coding for aspartate aminotransferase from the thermoacidophilic archaebacterium Sulfolobus solfataricus 62
Regulation of urokinase receptors in monocytelike U937 cells by phorbol ester phorbol myristate acetate. 62
Totale 9.662
Categoria #
all - tutte 35.147
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 35.147


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/202150 0 0 0 0 0 0 0 0 0 0 28 22
2021/2022503 16 0 12 2 5 9 8 16 78 35 80 242
2022/2023677 108 97 18 45 84 81 13 60 108 23 31 9
2023/2024392 27 77 36 15 22 12 3 48 10 10 96 36
2024/20253.031 200 208 12 32 125 192 343 163 208 306 954 288
2025/20265.304 573 388 472 541 961 294 505 359 741 367 103 0
Totale 10.797